FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's disease.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
31 08 2021
Historique:
received: 17 03 2021
revised: 30 06 2021
accepted: 11 08 2021
entrez: 1 9 2021
pubmed: 2 9 2021
medline: 15 2 2022
Statut: ppublish

Résumé

CAG repeat expansion in the HTT gene drives Huntington's disease (HD) pathogenesis and is modulated by DNA damage repair pathways. In this context, the interaction between FAN1, a DNA-structure-specific nuclease, and MLH1, member of the DNA mismatch repair pathway (MMR), is not defined. Here, we identify a highly conserved SPYF motif at the N terminus of FAN1 that binds to MLH1. Our data support a model where FAN1 has two distinct functions to stabilize CAG repeats. On one hand, it binds MLH1 to restrict its recruitment by MSH3, thus inhibiting the assembly of a functional MMR complex that would otherwise promote CAG repeat expansion. On the other hand, it promotes accurate repair via its nuclease activity. These data highlight a potential avenue for HD therapeutics in attenuating somatic expansion.

Identifiants

pubmed: 34469738
pii: S2211-1247(21)01092-5
doi: 10.1016/j.celrep.2021.109649
pmc: PMC8424649
pii:
doi:

Substances chimiques

HTT protein, human 0
Huntingtin Protein 0
MLH1 protein, human 0
MSH3 protein, human 0
Mlh1 protein, mouse 0
Multifunctional Enzymes 0
MutS Homolog 3 Protein 0
Endodeoxyribonucleases EC 3.1.-
Exodeoxyribonucleases EC 3.1.-
FAN1 protein, human EC 3.1.-
Fan1 protein, mouse EC 3.1.-
MutL Protein Homolog 1 EC 3.6.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109649

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200181/Z/15/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests A patent (application number 2105484.6) on the FAN1-MLH1 interaction and structural analogs for the treatment of disease has been filed by the University of Cambridge and UCL. The data presented in this patent are included in the main paper and supplemental information. G.B. is a co-founder and consultant for Adrestia Therapeutics. E.L.B. is the daughter of an advisor for Adrestia Therapeutics.

Références

Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
PLoS Genet. 2013 Oct;9(10):e1003930
pubmed: 24204323
EMBO J. 2014 Aug 1;33(15):1698-712
pubmed: 24966277
Cancer Cell. 2021 Jan 11;39(1):109-121.e5
pubmed: 33338427
Hum Mol Genet. 2019 Feb 15;28(4):650-661
pubmed: 30358836
Nat Commun. 2011;2:281
pubmed: 21505437
Neuron. 2015 Nov 18;88(4):667-77
pubmed: 26590344
Mol Syst Biol. 2019 Sep;15(9):e8994
pubmed: 31556486
Science. 2020 Mar 6;367(6482):
pubmed: 32139519
Genes Cells. 2020 Mar;25(3):175-186
pubmed: 31955481
Mol Cell Biol. 2009 Feb;29(3):907-18
pubmed: 19015241
Hum Mol Genet. 2009 Aug 15;18(16):3039-47
pubmed: 19465745
Brain. 2019 Jun 19;:
pubmed: 31216018
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2366-70
pubmed: 23341618
Cell. 2006 Jul 28;126(2):239-41
pubmed: 16873053
Hum Mol Genet. 2011 Nov 15;20(22):4395-410
pubmed: 21865299
Nat Rev Neurol. 2020 Oct;16(10):529-546
pubmed: 32796930
Am J Hum Genet. 2020 Jul 2;107(1):96-110
pubmed: 32589923
Neuroepidemiology. 2016;46(2):144-53
pubmed: 26824438
Anal Chem. 2019 Feb 5;91(3):1808-1814
pubmed: 30620560
Hum Mol Genet. 2020 Nov 4;29(18):3044-3053
pubmed: 32876667
Brain Commun. 2020 Aug 03;2(2):fcaa066
pubmed: 32954323
Nat Struct Mol Biol. 2010 Aug;17(8):926-8
pubmed: 20683477
J Biol Chem. 2010 Apr 9;285(15):11730-9
pubmed: 20154325
Science. 1996 Aug 23;273(5278):1109-11
pubmed: 8688098
Mol Cell Biol. 2014 Nov;34(21):3939-54
pubmed: 25135477
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1091-101
pubmed: 15279797
Science. 2016 Feb 19;351(6275):846-9
pubmed: 26797144
PLoS Genet. 2013;9(2):e1003280
pubmed: 23468640
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Mol Cell. 2010 Jul 9;39(1):36-47
pubmed: 20603073
Cell. 2010 Jul 9;142(1):65-76
pubmed: 20603015
Curr Colorectal Cancer Rep. 2017 Feb;13(1):73-80
pubmed: 28367107
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Mol Cell Proteomics. 2016 Mar;15(3):854-65
pubmed: 26560067
PLoS One. 2014 Oct 10;9(10):e109752
pubmed: 25303670
Cell. 2019 Aug 8;178(4):887-900.e14
pubmed: 31398342
PLoS Genet. 2020 Jun 26;16(6):e1008902
pubmed: 32589669
Am J Hum Genet. 2019 Jun 6;104(6):1116-1126
pubmed: 31104771
Nat Protoc. 2014 Jan;9(1):120-37
pubmed: 24356771
Nat Commun. 2014 Dec 11;5:5726
pubmed: 25500724
Lancet Neurol. 2020 Nov;19(11):930-939
pubmed: 33098802
J Med Genet. 1993 Dec;30(12):982-6
pubmed: 8133508
Nat Rev Dis Primers. 2015 Apr 23;1:15005
pubmed: 27188817
Sci Rep. 2017 May 2;7(1):1307
pubmed: 28465506

Auteurs

Robert Goold (R)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, London WC1N 3BG, UK.

Joseph Hamilton (J)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, London WC1N 3BG, UK.

Thomas Menneteau (T)

UK Dementia Research Institute, University College London, London WC1N 3BG, UK; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.

Michael Flower (M)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, London WC1N 3BG, UK.

Emma L Bunting (EL)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Sarah G Aldous (SG)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, London WC1N 3BG, UK.

Antonio Porro (A)

Institute of Molecular Cancer Research, University of Zurich, Zurich 8057, Switzerland.

José R Vicente (JR)

UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK.

Nicholas D Allen (ND)

School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.

Hilary Wilkinson (H)

CHDI Management/CHDI Foundation, Princeton, NJ 08540, USA.

Gillian P Bates (GP)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, London WC1N 3BG, UK.

Alessandro A Sartori (AA)

Institute of Molecular Cancer Research, University of Zurich, Zurich 8057, Switzerland.

Konstantinos Thalassinos (K)

Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London WC1E 6BT, UK; Institute of Structural and Molecular Biology, Birkbeck College, University of London, London WC1E 7HX, UK.

Gabriel Balmus (G)

UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK; Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0AH, UK. Electronic address: gb318@cam.ac.uk.

Sarah J Tabrizi (SJ)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute, University College London, London WC1N 3BG, UK. Electronic address: s.tabrizi@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH